Case Report
References
|
Amato L, Berti S, Fabbri P (2003). Warfarin-Induced Skin Necrosis. Skinmed. 2:127-130. Crossref |
||||
|
Brandenburg VM, Kramann R, Specht P, Ketteler M (2012). Calciphylaxis in CKD and beyond. Nephrol. Dial. Transplant. 27:1314-1318. Crossref |
||||
|
Chacon G, Nguyen T, Khan A, Sinha A, Maddirala S (2010). Warfarin-induced skin necrosis mimicking calciphylaxis: a case report and review of the literature. J. Drugs Dermatol. 9(7):859–863. Pubmed |
||||
|
Chan YC, Valenti D, Mansfield AO, Stansby G (2000). Warfarin induced skin necrosis. Br. J. Surg. 87(3):266-272. Crossref |
||||
|
Cochat P, Deloraine A, Rotily M, Olive F, Liponski I, Deries N (1995). Epidemiology of primary hyperoxaluria type 1. Société de Néphrologie and the Société de Néphrologie Pédiatrique. Nephrol. Dial. Transplant. 10 Suppl 8:3. Crossref |
||||
|
Essex DW, Wynn SS, Jin DK (1998). Late-onset warfarin-induced skin necrosis: case report and review of the literature. Am. J. Hematol. 57(3):233-7. Crossref |
||||
|
Hayashi M, Takamatsu I, Kanno Y, Abe T, Sato Y (2012). Japanese Calciphylaxis Study Group A case-control study of calciphylaxis in Japanese end-stage renal disease patients. Nephrol. Dial. Transplant. 27(4):1580-1584. Crossref |
||||
|
Hoppe B, Beck BB, Milliner DS (2009). The primary hyperoxalurias. Kidney Int. 75:1264. Crossref |
||||
|
Hoppe B, Langman CB (2003). A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr. Nephrol. 18:986. Crossref |
||||
|
Horton JD, Bushwick BM (1999). Warfarin therapy: evolving strategies in anticoagulation. Am. Fam. Physician 59:635-646 Pubmed |
||||
|
Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C (2010). Calciphylaxis in dialysis patients: to recognize and treat it as soon as possible.] La calciphylaxie chez le patient dialysé : la reconnaître pour la traiter aussitôt que possible. Nephrol. Ther. 6:499–504. Crossref |
||||
|
Kopp N, Leumann E (1995). Changing pattern of primary hyperoxaluria in Switzerland. Nephrol. Dial. Transplant. 10:2224. Pubmed |
||||
|
Levy M, Feingold J (2000). Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int. 58:925. Crossref |
||||
|
Muniesa C, Marcoval J, Moreno A (2004). Coumarin necrosis induced by renal insufficiency. Br. J. Dermatol. 151(2):502-4. Crossref |
||||
|
Nazarian RM, Van Cott EM, Zembowicz A, Duncan LM (2009). Warfarin-induced skin necrosis. J. Am. Acad. Dermatol. 61(2):325-32. Crossref |
||||
|
Reiter N, El-Shabrawi L, Leinweber B, Berghold A, Aberer E (2011). Calcinosis cutis: part I. Diagnostic pathway. J. Am. Acad. Dermatol. 65(1):1-12. Crossref |
||||
|
Tang X, Bergstralh EJ, Mehta RA, Vrtiska TJ, Milliner DS, Lieske JC (2015). Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria. Kidney Int. 87(3):623-31 Crossref |
||||
|
Watts RW (1994). Primary hyperoxaluria type I. QJM 87:593. Pubmed |
||||
| Xin C, Hu D, Li M (2014). Late onset warfarin-induced skin necrosis, a case report. G Ital Dermatol. Venereol. Nov 20. | ||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
